Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 13 professional analysts, the 12-month price target for Rhythm Pharmaceuticals stock ranges from a low of $65 to a high of $135. The average analyst price target of $101.92 forecasts a 4.15% increase in the stock price over the next year.

Price Target: $101.92 (+4.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$101.92	$102	$135
Change	-33.58%	+4.15%	+4.23%	+37.95%

Analyst Ratings

The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	7	8	8	8	8	8
Buy	4	4	4	4	5	5
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $80 → $100	Strong Buy	Maintains	$80 → $100	+2.19%	Aug 7, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $100 → $109	Buy	Maintains	$100 → $109	+11.38%	Aug 6, 2025
Jonathan Wolleben JMP Securities	JMP Securities	Buy Maintains $130 → $135	Buy	Maintains	$130 → $135	+37.95%	Aug 6, 2025
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy Maintains $119 → $120	Strong Buy	Maintains	$119 → $120	+22.62%	Aug 6, 2025
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $92 → $105	Strong Buy	Maintains	$92 → $105	+7.30%	Jul 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

179.39M

Increased by 37.86%

from 130.13M

Revenue Next Year

309.84M

Increased by 72.72%

from 179.39M

EPS This Year

-2.83

from -4.34

EPS Next Year

-1.62

from -2.83

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	3.15M	23.64M	77.43M	130.13M	179.39M	309.84M	561.86M
Revenue Growth	-	-	649.46%	227.56%	68.06%	37.86%	72.72%	81.34%
EPS	-3.04	-1.40	-3.47	-3.20	-4.34	-2.83	-1.62	1.46
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	66.89
No. Analysts	-	-	-	-	-	14	15	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	193.8M	420.0M	719.9M
Avg	179.4M	309.8M	561.9M
Low	166.6M	226.8M	443.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	48.9%	134.1%	132.3%
Avg	37.9%	72.7%	81.3%
Low	28.0%	26.4%	43.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.44	-0.23	3.16
Avg	-2.83	-1.62	1.46
Low	-3.40	-2.79	-0.32

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.